Analyst Price Targets — CC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 13, 2026 11:03 am | — | Alembic Global | $30.00 | $24.67 | TheFly | Chemours price target raised to $30 from $24 at Alembic Global |
| May 11, 2026 12:16 pm | Vincent Andrews | Morgan Stanley | $21.00 | $24.45 | TheFly | Chemours price target raised to $21 from $17 at Morgan Stanley |
| May 11, 2026 11:33 am | — | RBC Capital | $29.00 | $23.04 | TheFly | Chemours price target raised to $29 from $26 at RBC Capital |
| May 8, 2026 2:43 pm | — | UBS | $30.00 | $22.86 | TheFly | Chemours price target raised to $30 from $29 at UBS |
| May 6, 2026 11:51 am | John Roberts | Mizuho Securities | $30.00 | $27.93 | TheFly | Chemours price target raised to $30 from $25 at Mizuho |
| April 28, 2026 10:44 am | Peter Osterland | Truist Financial | $30.00 | $26.48 | TheFly | Chemours price target raised to $30 from $27 at Truist |
| April 10, 2026 12:26 pm | Arun Viswanathan | RBC Capital | $26.00 | $22.86 | TheFly | Chemours price target raised to $26 from $21 at RBC Capital |
| April 9, 2026 12:14 pm | — | UBS | $29.00 | $21.84 | TheFly | Chemours price target raised to $29 from $23 at UBS |
| April 9, 2026 10:10 am | — | Truist Financial | $27.00 | $21.84 | TheFly | Chemours price target raised to $27 from $21 at Truist |
| February 23, 2026 4:57 pm | Laurence Alexander | Jefferies | $17.00 | $18.16 | StreetInsider | Chemours (CC) PT Raised to $17 at Jefferies |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for CC

[url="]Interactive Brokers[/url] (Nasdaq: IBKR), an automated global broker, today announced the addition of nine new tokens for trading through zerohash and t

Stockholm, July 1st, 2026 – Virtune today announces the completion of the rebalancing for the Virtune Stablecoin Index ETP (SE0026821282), listed on Nasdaq Stockholm, Nasdaq Helsinki and Xetra.

Chemours (CC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Chemours Reaches Agreement with U.S. EPA to Resolve Claims Relating to PFAS PR Newswire WILMINGTON, Del., June 2

The settlement resolves the federal government's claims relating to discharge of PFAS compounds across three current operating sites, as well as certain environmental claims by the State of West Virginia. Chemours is expected to pay EPA and WVDEP a $22.5 million civil penalty over a three-year period, and fund $90 million in additional mitigation projects over the next 15 years to further reduce PFAS emissions and…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
